- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03840655
Fluorescent Thoracoscopy Used in Surgery for Palmar Hyperhidrosis
February 12, 2019 updated by: Jun Wang, Peking University People's Hospital
T3/T4 endoscopic thoracic sympathicotomy is a widely accepted and effective treatment for primary palmar hyperhidrosis.
However, sympathetic ganglions are invisible with traditional thoracoscopy and until now, the location of ganglions are confirmed by rib indirectly.
The team from thoracic department of Peking University People's Hospital discovered that the sympathetic ganglions can be visualized with fluorescent thoracoscopy.
Thus, investigators want to apply fluorescent thoracoscopy in sympathicotomy of palmar hyperhidrosis, to conduct a more precise operation and compare the efficiency of the novel and traditional methods.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
89
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, +86-010
- Peking University People's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 75 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients suffering from primary palmar hyperhidrosis
Description
Inclusion Criteria:
- Diagnosed with primary palmar hyperhydrosis.
- Accept surgical treatment and signed informed consent.
Exclusion Criteria:
- Liver dysfunction.
- Allergic to indocyanine green.
- Can't tolerate thoracoscopic surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
palmar hyperhidrosis
VATS R4 Sympathicotomy performed on all patients.
Fluorescent thoracoscopy was used to identify the shifting mode of sympathetic ganglions.
|
Sympathicotomy performed by near-infrared imaging thoracoscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anatomical variation of the sympathetic ganglions
Time Frame: during surgery
|
Record the spatial relationship between sympathetic ganglions and ribs, for example: T3/R4 represents the T3 sympathetic ganglion is located on the 4th rib.
|
during surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improvement of palmar sweating
Time Frame: 1 month after surgery
|
Use questionnaire including 3 descriptive names of scale ( over dry, comfortable and wet) to record the surgical effect on palmar sweating.
|
1 month after surgery
|
Degree of compensatory hyperhidrosis
Time Frame: 1 month after surgery
|
Use questionnaire including 4 descriptive names of scale ( none, mild, moderate and severe) to record the side effect (compensatory hyperhidrosis) of this surgery.
|
1 month after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 16, 2017
Primary Completion (Actual)
September 1, 2018
Study Completion (Actual)
September 1, 2018
Study Registration Dates
First Submitted
February 9, 2019
First Submitted That Met QC Criteria
February 12, 2019
First Posted (Actual)
February 15, 2019
Study Record Updates
Last Update Posted (Actual)
February 15, 2019
Last Update Submitted That Met QC Criteria
February 12, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017PHB101-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Palmar Hyperhidrosis
-
Tmaer Youssef MohamedCompletedPalmar Hyperhidrosis
-
Journey Medical CorporationCompletedPalmar HyperhidrosisUnited States
-
Atacama TherapeuticsActive, not recruitingHyperhidrosis | Palmar HyperhidrosisUnited States
-
Pariser, Robert J., M.D.Virginia Clinical Research, Inc.CompletedHyperhidrosis | Sweat Gland Diseases | Skin Diseases | Palmar HyperhidrosisUnited States
-
Atacama TherapeuticsCompletedPalmar HyperhidrosisUnited States
-
Ain Shams UniversityNot yet recruitingPrimary Palmar HyperhydrosisEgypt
-
Miramar LabsCompletedAxillary HyperhidrosisCanada
-
Commons Aesthetic Plastic SurgerySound Surgical Technologies, LLC.CompletedAxillary HyperhidrosisUnited States
-
Botanix PharmaceuticalsCompletedAxillary HyperhidrosisUnited States
-
miraDry, Inc.Withdrawn
Clinical Trials on Near-Infrared Imaging Thoracoscopy
-
University of WashingtonBlaze Bioscience Inc.RecruitingStage III Lip and Oral Cavity Cancer AJCC v8 | Oral Cavity Squamous Cell Carcinoma | Stage I Lip and Oral Cavity Cancer AJCC v8 | Stage II Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8United States
-
Marmara UniversityCompleted
-
University of California, IrvineBeckman Laser Institute University of California Irvine; Brooke Army Medical...CompletedHemorrhagic ShockUnited States
-
Fujian Medical UniversityActive, not recruitingGastric Cancer | SurgeryChina
-
Maastricht University Medical CenterUnknownEndometriosisNetherlands
-
Leiden University Medical CenterRecruiting
-
Leiden University Medical CenterErasmus Medical CenterRecruitingPerfusion | Traumatic Injury | Fluorescence ImagingNetherlands
-
Leiden University Medical CenterUnknown
-
University of PittsburghCompletedSolitary Pulmonary NodulesUnited States
-
University of AarhusRigshospitalet, Denmark; InCor Heart Institute; Hospital das Clínicas de Ribeirão...CompletedUniventricular Heart | Lymphatic Abnormalities | Lymphatic EdemaDenmark